1. Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial. (3rd October 2022) Authors: Mahaffey, K W; Baeres, F M M; Bakris, G; Bosch-Traberg, H; Gislum, M; Lawson, J; Mann, J F E; Mersebach, H; Perkovic, V; Rossing, P; Tuttle, K; Pratley, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗